“…Arterial-venous transit time (AVTT) has demonstrated utility in diabetic retinopathy, glaucoma, hypoperfusion retinopathy, central retinal artery occlusion, central retinal vein occlusion, retinitis pigmentosa, Rubinstein-Taybi syndrome, and coronary slow flow. 10 , 11 , 12 , 13 , 14 , 15 , 16 …”